InvestorsHub Logo
Followers 24
Posts 883
Boards Moderated 0
Alias Born 02/28/2017

Re: Stiggie post# 26459

Tuesday, 02/11/2020 8:28:47 AM

Tuesday, February 11, 2020 8:28:47 AM

Post# of 54907
External beta testing and validation is needed for a full roll out and for doctors and facilities to accept it. The positives are (think George was the guy saying Houston never heard of Artguide) that there’s over 1000 people treated and it’s exceeding expectations. Next step I’d imagine is a white paper for the scientific community and then we push the go button.

This is a major milestone as it’s independent validation by the top fertility clinic in the US. This will be extremely important for Thermo and China and speeds that process up.

Next (depending when people conceived) will be happy mother’s and babies. How powerful will that be!!
Also very important is that Houston are carrying out an IRB retrospective study on ART outcomes and this will be extremely useful as a validation metric for ArtGuide.
All coming together

Also the the volume that somebody Eluded to. The illusion of volume is different than actual volume. Paulson swapping with Cdel and back again is not volume, it’s market makers screwing around